Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

104.52 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,796
Open 104.52
Bid (Size) 104.60 (100)
Ask (Size) 108.70 (11,000)
Prev. Close 104.52
Today's Range 104.52 - 104.52
52wk Range 47.25 - 104.57
Shares Outstanding 67,604,097
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Healthcare Stocks with Open Questions
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
1 Cash-Producing Stock on Our Buy List and 2 Facing Challenges
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc... 
Via StockStory

Performance

YTD
+55.4%
+55.4%
1 Month
+11.3%
+11.3%
3 Month
+33.1%
+33.1%
6 Month
+57.0%
+57.0%
1 Year
+34.3%
+34.3%

More News

Read More
News headline image
Lantheus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus' LNTH-2513 (18F-GP1) PET/CT Awarded SNMMI’s Image of the Year
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus (NASDAQ:LNTH) Beats Q1 Estimates, Guides In Line, And Wall Street Is Paying Attention ↗
Via Chartmill
Lantheus Holdings (NASDAQ:LNTH): A Decent Value Pick in Diagnostic Imaging ↗
Via Chartmill
News headline image
Why This Fund Cashed Out of a Stock That Soared 250% in Just One Year ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Lantheus to Present at the William Blair 46th Annual Growth Stock Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Highlights New Radiodiagnostic Data at the 2026 SNMMI Annual Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Announces Presentation of Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
3 Hyped Up Stocks with Warning Signs
Via StockStory
News headline image
Lantheus (LNTH) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
These Analysts Raise Their Forecasts On Lantheus After Upbeat Q1 Results ↗
Via Benzinga
News headline image
Lantheus Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Lantheus (NASDAQ:LNTH) Surprises With Q1 CY2026 Sales
Via StockStory
News headline image
Lantheus Reports First Quarter 2026 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus (LNTH) Q1 Earnings Report Preview: What To Look For
Via StockStory
News headline image
Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
1 Healthcare Stock to Target This Week and 2 We Ignore
Via StockStory
News headline image
3 Profitable Stocks We Think Twice About
Via StockStory
News headline image
3 Cash-Producing Stocks Walking a Fine Line
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Ignore
Via StockStory
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
Via StockStory
News headline image
Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application ↗
Via Stocktwits
News headline image
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
From Lantheus Holdings, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Lantheus Holdings, Inc. - Common Stock publicly traded?
Yes, Lantheus Holdings, Inc. - Common Stock is publicly traded.
What exchange does Lantheus Holdings, Inc. - Common Stock trade on?
Lantheus Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lantheus Holdings, Inc. - Common Stock?
The ticker symbol for Lantheus Holdings, Inc. - Common Stock is LNTH on the Nasdaq Stock Market
What is the current price of Lantheus Holdings, Inc. - Common Stock?
The current price of Lantheus Holdings, Inc. - Common Stock is 104.52
When was Lantheus Holdings, Inc. - Common Stock last traded?
The last trade of Lantheus Holdings, Inc. - Common Stock was at 06/12/26 04:00 PM ET
What is the market capitalization of Lantheus Holdings, Inc. - Common Stock?
The market capitalization of Lantheus Holdings, Inc. - Common Stock is 7.07B
How many shares of Lantheus Holdings, Inc. - Common Stock are outstanding?
Lantheus Holdings, Inc. - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.